Healthy Skepticism Library item: 19512

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Studdert DM, Mello MM, Brennan TA
Financial conflicts of interest in physician relationships with pharmaceutical companies--self regulation in the shadow of federal prosecution.
NEJM 2004 Oct 28; 351:1891-1900
http://www.nejm.org/doi/full/10.1056/NEJMlim042229

Abstract:

The past two years have witnessed extraordinary regulatory ferment in the area of conflicts of interest involving physicians, especially conflicts arising in relationships with the pharmaceutical industry. Professional regulatory bodies, the pharmaceutical industry, and the government have all decided that physicians and drug manufacturers need stronger advice about appropriate relationships. In 2002, three leading professional organizations — the American Medical Association,1 the American College of Physicians,2 and the Accreditation Council for Continuing Medical Education3 — issued or revamped guidelines regarding physicians’ interactions with drug companies. In July 2002, acting through its trade association, the Pharmaceutical Research and Manufacturers of America, . . .